• Explore /
  • Poster
  • / A multicenter, open-label, randomized phase II study evaluating adjuvant gemcitabine plus cisplatin (GC) and capecitabine with concurrent capecitabine radiotherapy (CAPE-RT) in patients with operated gallbladder adenocarcinoma (GBC): The GECCOR-GB trial.

A multicenter, open-label, randomized phase II study evaluating adjuvant gemcitabine plus cisplatin (GC) and capecitabine with concurrent capecitabine radiotherapy (CAPE-RT) in patients with operated gallbladder adenocarcinoma (GBC): The GECCOR-GB trial.

Abstract Video & Slides Poster

Authors

null

Anant Ramaswamy

Tata Memorial Hospital (HBNI), Mumbai, India

Anant Ramaswamy , Vikas S. Ostwal , Reena Engineer , Manali Parulekar , Sarika Mandavkar , Nanda Aier , Prabhat Ghanshyam Bhargava , Sujay Srinivas , Shraddha Patkar , RAHUL KRISHNATRY , Shivakumar Gudi , Akhil Kapoor , Durgatosh Pandey , Swapnil Patel , Abhishek Shinghal , Alok Goel , Tapas Kumar Dora , Debashish Chaudhary , Suman Kumar Ankathi , Mahesh Goel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Local-Regional Disease

Clinical Trial Registration Number

CTRI/2019/05/019323

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4017)

DOI

10.1200/JCO.2023.41.16_suppl.4017

Abstract #

4017

Poster Bd #

338

Abstract Disclosures

Similar Posters

First Author: Yongkun Sun

First Author: Feng Wang

First Author: Yelena Y. Janjigian

First Author: Richard D. Kim